XML 1052 R6.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Total
Class A [Member]
Common Stock [Member]
Class A [Member]
Class B [Member]
Common Stock [Member]
Class B [Member]
Beginning balance at Dec. 31, 2016 $ 54,286 $ 33,220 $ 316,195 $ 404,345 $ 112   $ 532  
Beginning balance (in shares) at Dec. 31, 2016         2,623,000   12,461,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 0 0 18,323 18,323 $ 0   $ 0  
Foreign currency translation adjustment, net of tax 0 522 0 522 0   0  
Change in unrealized gain (loss) on investments, net of tax 0 12,649 0 12,649 0   0  
Common stock dividends 0 0 (16,302) (16,302) 0   0  
Repurchase of common stock (360) 0 (1,516) (1,880) $ 0   $ (4)  
Repurchase of common stock (in shares)         0   (85,000)  
Restricted stock grants 1,152 0 0 1,154 $ 0   $ 2  
Restricted stock grants (in shares)         0   48,000  
Ending balance at Dec. 31, 2017 55,078 46,391 316,700 418,811 $ 112   $ 530  
Ending balance (in shares) at Dec. 31, 2017         2,623,000   12,424,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Cumulative effect of adoption, net of tax | ASU 2016-01 [Member] 0 (46,157) 46,157 0 $ 0   $ 0  
Cumulative effect of adoption, net of tax | ASU 2018-02 [Member] 0 117 (117) 0 0   0  
Net income (loss) 0 0 (34,075) (34,075) 0   0  
Foreign currency translation adjustment, net of tax 0 (830) 0 (830) 0   0  
Change in unrealized gain (loss) on investments, net of tax 0 (6,868) 0 (6,868) 0   0  
Common stock dividends 0 0 (16,835) (16,835) 0   0  
Repurchase of common stock (832) 0 (3,755) (4,596) $ 0   $ (9)  
Repurchase of common stock (in shares)         (8,000)   (192,000)  
Restricted stock grants 474 0 0 475 $ 0   $ 1  
Restricted stock grants (in shares)         0   22,000  
Ending balance at Dec. 31, 2018 54,720 (7,347) 308,075 356,082 $ 112   $ 522  
Ending balance (in shares) at Dec. 31, 2018         2,615,000   12,254,000  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 0 0 7,347 7,347 $ 0   $ 0  
Foreign currency translation adjustment, net of tax 0 645 0 645 0   0  
Change in unrealized gain (loss) on investments, net of tax 0 16,071 0 16,071 0   0  
Common stock dividends 0 0 (5,857) (5,857) 0   0  
Repurchase of common stock (2,896) 0 (8,577) (11,501) $ (1)   $ (27)  
Repurchase of common stock (in shares)         (12,000) (11,989) (665,000) (665,099)
Restricted stock grants 1,525 0 0 1,529 $ 0   $ 4  
Restricted stock grants (in shares)         0   87,000  
Ending balance at Dec. 31, 2019 $ 53,349 $ 9,369 $ 300,988 $ 364,316 $ 111   $ 499  
Ending balance (in shares) at Dec. 31, 2019         2,603,000   11,676,000